用于测试新型中风治疗设备的体外血液凝固与溶解

In Vitro Blood Clot Formation and Dissolution for Testing New Stroke-Treatment Devices.

作者信息

Wood Kayla, Stephens Sam E, Xu Feng, Hazaa Alshaimaa, Meek James C, Jensen Hanna K, Jensen Morten O, Wickramasinghe Ranil

机构信息

Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR 72701, USA.

Interventional Radiology Clinic, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

出版信息

Biomedicines. 2022 Aug 3;10(8):1870. doi: 10.3390/biomedicines10081870.

Abstract

Strokes are among the leading causes of death worldwide. Ischemic stroke, due to plaque or other buildup blocking blood flow to the brain, is the most common type. Although ischemic stroke is treatable, current methods have severe shortcomings with high mortality rates. Clot retrieval devices, for example, can result in physically damaged vessels and death. This study aims to create blood clots that are representative of those found in vivo and demonstrate a new method of removing them. Static blood clots were formed using a 9:1 ratio of whole sheep blood and 2.45% calcium chloride solution. This mixture was heated in a water bath at 37 °C for approximately one hour until solidified. Following clot solidification, human plasmin was introduced by various methods, including soaking, injection, and membrane perfusion, and the resulting dissolution percentages were determined. Different clot types, representative of the wide range found physiologically, were also manufactured and their dissolution characteristics evaluated. A method to reproducibly create blood clots, characteristic of those found in vivo, is essential for the production of stroke retrieval devices that can efficiently and effectively remove clots from patients with low mortality rates and little/no damage to the surrounding vessels.

摘要

中风是全球主要死因之一。缺血性中风是最常见的类型,它是由于斑块或其他堵塞物阻碍了大脑的血液流动所致。尽管缺血性中风是可治疗的,但目前的方法存在严重缺陷,死亡率很高。例如,血栓清除装置可能会导致血管物理损伤和死亡。本研究旨在制造出与体内发现的血栓具有代表性的血栓,并展示一种清除它们的新方法。使用全羊血与2.45%氯化钙溶液按9:1的比例形成静态血栓。将该混合物在37°C的水浴中加热约一小时直至凝固。血栓凝固后,通过多种方法引入人纤溶酶,包括浸泡、注射和膜灌注,并测定由此产生的溶解百分比。还制造了代表生理上广泛存在的不同类型的血栓,并评估了它们的溶解特性。一种可重复制造出具有体内血栓特征的血栓的方法,对于生产能够以低死亡率且对周围血管几乎没有/没有损伤的情况下高效、有效地从患者体内清除血栓的中风恢复装置至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3612/9405282/3a94c1c9e2e7/biomedicines-10-01870-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索